好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Suicidal Behavior in Parkinson Disease
Movement Disorders
P2 - Poster Session 2 (5:30 PM-6:30 PM)
10-025

To determine frequency of lifetime suicidal behavior in Parkinson disease (PD). 

PD is associated with depression and demoralization, but it is unknown whether suicidality is increased in PD. 

PD and non-PD controls completed online surveys, assessing lifetime suicidality with the Suicidal Behavior Questionnaire-revised (SBQ-R). PD was defined by self-report and having a neurologist PD diagnosis or taking levodopa. Depression was assessed using the Brief Lifetime Depression Scale. Suicide risk was high if SBQ-R was >= 7. Questions included “Have you ever thought about or attempted to kill yourself?” Responses included: “No”, “It was a passing thought.”; “I have had a plan to kill myself.”; “I have attempted to kill myself.” Demoralization was assessed using the Kissane Demoralization Scale and Diagnostic Criteria for Psychosomatic Research.

178 PD and 182 control subjects were comparable in age (64.9±8.1 years), gender (51.4% women), income (83.6% middle or high income), and education (87.5% college or higher). PD patients were no more likely than controls to have high suicide risk (12.9% vs 15.9%; p=0.42) and significantly less likely to have had a lifetime suicide attempt or plan (2.8% vs 7.7; p=0.03). This was despite PD patients having significantly higher prevalence of lifetime depression (40.4% vs. 20.9%; p<0.0001) and demoralization (23.0% vs. 11.0%; p=0.002). SBQ-R score was equivalent in PD and controls (4.4±2.2 vs. 4.5±2.1; p=0.67). In the overall cohort, SBQ-R score was significantly positively associated with demoralization (1.32 units 95% CI [0.72,1.93]; p<0.0001), depression (0.91 units [0.40,1.41]; p=0.0004), and past drug abuse history, and marginally negatively with PD (-0.43 units [-0.86,0.004]; p=0.053). For PD, SBQ-R was significantly positively associated with demoralization [1.91 units (0.83,2.99)], drug abuse, and being widowed, but not with depression [-0.75 units(-1.7,0.24)].

Suicide risk is no higher in PD than in age-sex-socioeconomic-matched controls. Demoralization is a risk for suicide, particularly for PD patients. 
Authors/Disclosures
Brian Koo, MD
PRESENTER
Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Nada Ahmed, MD (Prisma Health) Dr. Ahmed has nothing to disclose.
No disclosure on file
Rucha Bahekar, MBBS (UAMS) Dr. Bahekar has nothing to disclose.
Priyanka Chilakamarri, MD (Division of Sleep, Hosp University of Pennsylvania) Dr. Chilakamarri has nothing to disclose.
Mohamed Elfil, MBBCh Dr. Elfil has nothing to disclose.
No disclosure on file
Pooja SirDeshpande, MBBS No disclosure on file
Elan D. Louis, MD, MS, FAAN (University of Texas Southwestern Medical Center) Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.